LegacyXChange (LEGX) 10-Q 16 Nov 15 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Sep. 30, 2015	Nov. 16, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	LegacyXChange, Inc.
Entity Central Index Key	1,423,579
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,016
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		44,880,056

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Mar. 31, 2015
CURRENT ASSETS:
Cash	$ 562	$ 4,362
Prepaid expenses	39,302	$ 28,801
Inventories	570
Total Current Assets	40,434	$ 33,163
TOTAL ASSETS	40,434	33,163
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	132,284	113,747
Accrued officer salary and director fees	4,250	$ 8,050
Loan payable	25,000
Derivative liabilities	981,639	$ 1,088,085
Total Current Liabilities	1,143,173	1,209,882
Convertible notes payable, net of discount	117,862	70,087
TOTAL LIABILITIES	$ 1,261,035	$ 1,279,969
COMMITMENTS (Note 10)
STOCKHOLDERS' DEFICIT:
Preferred stock ($0.001 par value; 10,000,000 shares authorized; No share issued or outstanding at September 30, 2015 and March 31, 2015)
Common stock, ($0.001 par value; 190,000,000 shares authorized; 44,630,056 and 36,951,165 shares issued and outstanding at September 30, 2015 and March 31, 2015, respectively)	$ 44,630	$ 36,951
Additional paid-in capital	8,734,413	8,332,206
Accumulated deficit	(9,999,644)	(9,615,963)
TOTAL STOCKHOLDERS' DEFICIT	(1,220,601)	(1,246,806)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 40,434	$ 33,163

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Mar. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	190,000,000	190,000,000
Common stock, shares issued	44,630,056	36,951,165
Common stock, shares outstanding	44,630,056	36,951,165

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
REVENUE, NET		$ (365)		$ 358
COST OF REVENUE		229		1,536
GROSS LOSS		(594)		(1,178)
OPERATING EXPENSES
Compensation and related taxes	$ 33,795	52,859	$ 67,766	86,562
Professional fees	105,490	20,055	216,089	94,264
Other selling, general and administrative	10,293	8,222	25,571	22,711
TOTAL OPERATING EXPENSES	149,578	81,136	309,426	203,537
LOSS FROM OPERATIONS	(149,578)	$ (81,730)	(309,426)	$ (204,715)
OTHER INCOME (EXPENSE)
Interest expense	(117,120)		(163,624)
Initial derivative expense	(47,382)		(166,837)
(Loss) gain from change in fair value of derivative liabilities	$ (3,294)		$ 256,206
Loss on settlement of loans				$ (5,510)
TOTAL OTHER INCOME (EXPENSE), NET	$ (167,796)		$ (74,255)	(5,510)
NET LOSS	$ (317,374)	$ (81,730)	$ (383,681)	$ (210,225)
NET LOSS PER COMMON SHARE
Basic and diluted	$ (0.0073)	$ (0.0022)	$ (0.0095)	$ (0.0059)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING:
Basic and diluted	43,273,433	36,906,346	40,443,588	35,340,520

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity Deficit - 6 months ended Sep. 30, 2015 - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Mar. 31, 2015	$ (1,246,806)		$ 36,951	$ 8,332,206	$ (9,615,963)
Beginning balance, shares at Mar. 31, 2015			36,951,165
Stock issued for services, value	81,990		$ 1,730	80,260
Stock issued for services, shares			1,730,000
Stock issued for accounts payable - related party, value	36,667		$ 909	35,758
Stock issued for accounts payable - related party, shares			908,807
Stock issued for notes conversion, value	88,510		$ 4,425	84,085
Stock issued for notes conversion, shares			4,425,500
Stock issued for accrued interest, value	10,792		$ 540	10,252
Stock issued for accrued interest, shares			539,584
Stock issued for loan fees, value	3,600		$ 75	3,525
Stock issued for loan fees, share			75,000
Reclassification of derivative liabilities upon notes conversion	(188,327)			$ 188,327
Net loss	(383,681)				$ (383,681)
Ending balance at Sep. 30, 2015	$ (1,220,601)		$ 44,630	$ 8,734,413	$ (9,999,644)
Ending balance, shares at Sep. 30, 2015			44,630,056

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (383,681)	$ (210,225)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses	64,235	$ 68,508
Stock issued for loan fees	$ 3,600
Loss on settlement of loans		$ 5,510
Amortization of debt discount	$ 136,285
Initial fair value of derivative liabilities	166,837
Gain from change in fair value of derivative liabilities	(256,206)
Changes in operating assets and liabilities:
Prepaid expenses	$ 7,254	$ 3,095
Security deposit		$ 636
Inventories	$ (570)
Accounts payable and accrued liabilities	$ 65,996	$ 3,726
Deferred revenue		(327)
Accrued officer salary and director fees	$ (3,800)	14,300
Due to shareholders		(3,271)
Due to officer		(198)
Net cash used in operating activities	$ (200,050)	(118,246)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds received from convertible notes advances		$ 55,000
Proceeds received from loan payable	$ 25,000
Proceeds received from convertible notes	$ 171,250
Proceeds received from sale of stock		$ 71,895
Net cash provided by financing activities	$ 196,250	126,895
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(3,800)	8,649
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	4,362	9,345
CASH AND CASH EQUIVALENTS - END OF PERIOD	$ 562	$ 17,994
Cash paid for:
Interest
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for future services	$ 37,490	$ 33,060
Stock issued for accrued liabilities	$ 36,667
Stock issued for loans' principal		$ 20,000
Stock issued for convertible notes' principal	$ 88,510
Stock issued for accrued interest	$ 10,792	$ 2,000
Stock issued for common stock subscription advances		$ 113,525
Initial debt discount recorded on convertible notes	$ 171,250
Derivative liabilities reclassified to additional paid-in capital upon notes conversion	$ 188,327

Organization and Nature of Oper

Organization and Nature of Operations	6 Months Ended
	Sep. 30, 2015
Organization and Nature of Operations [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS	NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS LegacyXChange, Inc. (formerly True 2 Beauty, Inc.) (the “Company”) was originally incorporated as Burrow Mining, Inc., a Nevada corporation, on December 11, 2006. In February 2010, the Company shifted its focus to the beauty industry and later amended its Articles of Incorporation and changed its name to True 2 Beauty, Inc. to better reflect its new business focus. On July 10, 2012, the Company formed a new wholly owned subsidiary True2Bid, Inc. (“True2Bid”), which was incorporated in the state of Nevada. This subsidiary’s name was changed to LegacyXChange, Inc. (“LegacyXChange”) in December 2014. The Company continued to sell existing inventory of beauty products through May 2013 when the final inventory was sold. LegacyXChange plans to operate an online e-commerce platform focused on delivering users a wide array of sports and entertainment related products that can be won in an action packed environment of a live auction. On July 2, 2015, pursuant to a Certificate of Dissolution filing with the Nevada Secretary of State, the Company dissolved LegacyXChange, Inc. (formerly True2Bid, Inc.) to allow for the change in name of its parent company, True 2 Beauty, Inc., to LegacyXChange, Inc. The Company plans on launching its website, LegacyXChange.com, for the trading of collectibles and memorabilia across numerous product categories. Following secure chain of custody protocols that guarantee authenticity from origination, and utilizing unique proprietary DNA “Marks” that cannot be counterfeited, the Company’s anticipated inventory of collectibles will be permanently marked with DNA, which can only be verified through DNA analysis. The Company’s goal is to provide the ongoing ability to guarantee authenticity of items with 100% surety. The Company will track ownership for all Original items, and only the Company can verify authenticity. The Company will work with athletes and celebrities as they create high valued new collectibles, items that will differentiate from those already in the marketplace. The site will also allow non-“Marked” third party collectible items to be listed and sold. However, any third party items, which claim to have authentic signatures, will have to provide documentation of authenticity from a Company-approved expert authentication company. The site will offer sellers multiple opportunities to advertise and promote the sale of items.

Basis of Presentation, Going Co

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2015
Organization and Nature of Operations [Abstract]
BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICITES Basis of presentation Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented. The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the years ended March 31, 2015 and 2014 included in the Company’s Form 10-K. Going concern These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $383,681 and $210,225 for the six months ended September 30, 2015 and 2014, respectively, and net cash used in operations of $200,050 and $118,246 for the six months ended September 30, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,999,644, $1,220,601 and $1,102,739, respectively, at September 30, 2015, did not generate any revenue for the six months ended September 30, 2015 and had a gross loss for the six months ended September 30, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The unaudited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized. Use of estimates The preparation of the unaudited consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the three and six months ended September 30, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees. Fair value of financial instruments and fair value measurements The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: ● Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. ● Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. ● Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the unaudited consolidated balance sheets for cash, inventories, accounts payable and accrued liabilities, accrued officer salary and director fees, and loan payable, approximate their fair market value based on the short-term maturity of these instruments. Certain financial instruments, such as certain accrued liabilities, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price. The following table reflects changes for the six months ended September 30, 2015 for all financial assets and liabilities categorized as Level 3: Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Increase in fair value of fixed monetary obligation - 12,000 Initial fair value of derivative liabilities attributable to conversion feature and warrants 338,087 - Reclassification of derivative liabilities upon notes conversion (188,327 ) - Decrease in fair value of fixed monetary obligation - (18,667 ) Gain from change in the fair value of derivative liabilities (256,206 ) - Balance as of September 30, 2015 $ 981,639 $ - ASC 825-10 “ Financial Instruments , Cash and cash equivalents Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at September 30, 2015 and March 31, 2015. Inventories and cost of revenue Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. Inventories of finished goods totaled $570 and $0 at September 30, 2015 and March 31, 2015, respectively. Revenue recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows: ● Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred. ● To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life, which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days. Stock-based compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Income taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of September 30, 2015 and March 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying unaudited consolidated financial statements. Shipping costs Shipping costs are included in other selling, general and administrative expense and totaled $2 and $20 for the three months ended September 30, 2015 and 2014, respectively. Shipping costs totaled $2 and $115 for the six months ended September 30, 2015 and 2014, respectively. Advertising Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the three and six months ended September 30, 2015 and 2014. Research and development Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the three and six months ended September 30, 2015 and 2014. Basic and diluted earnings per share Pursuant to ASC 260-10-45, basic earnings per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the three and six months ended September 30, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at September 30, 2015 and 2014 included the following: September 30, 2015 September 30, 2014 Stock warrants 4,473,315 1,048,315 Total 4,473,315 1,048,315 Related parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged. Recent accounting pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.

Prepaid Expenses

Prepaid Expenses	6 Months Ended
	Sep. 30, 2015
Prepaid Expenses [Abstract]
PREPAID EXPENSES	NOTE 3 – PREPAID EXPENSES At September 30, 2015 and March 31, 2015, prepaid expenses consisted of the following: September 30, 2015 March 31, 2015 Prepaid professional service fees $ 38,952 $ 28,801 Prepaid other expense 350 - $ 39,302 $ 28,801

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	6 Months Ended
	Sep. 30, 2015
Accounts Payable and Accrued Liabilities [Abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES At September 30, 2015 and March 31, 2015, accounts payable and accrued liabilities consisted of the following: September 30, 2015 March 31, 2015 Accrued interest $ 30,640 $ 17,693 Accrued professional fees 65,688 67,364 Accrued payroll taxes 33,456 28,690 Other 2,500 - $ 132,284 $ 113,747

Accrued Officer Salary and Dire

Accrued Officer Salary and Director Fees	6 Months Ended
	Sep. 30, 2015
Accrued Officer Salary and Director Fees [Abstract]
ACCRUED OFFICER SALARY AND DIRECTOR FEES	NOTE 5 – ACCRUED OFFICER SALARY AND DIRECTOR FEES In connection with the employment of a board of director member, the Company has agreed to compensate him as follows: an initial payment of $1,500 and quarterly payments of $1,500 during the term, which he serves as a director of the Company. At September 30, 2015 and March 31, 2015, the amount due to this director was $3,250 and $4,750, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets. At September 30, 2015 and March 31, 2015, the accrued and unpaid CEO’s salary was $1,000 and $3,300, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets. At September 30, 2015 and March 31, 2015, accrued officer salary and director fees consisted of the following: September 30, 2015 March 31, 2015 Accrued director's salary $ 3,250 $ 4,750 Accrued officer’s salary 1,000 3,300 $ 4,250 $ 8,050

Loan Payable

Loan Payable	6 Months Ended
	Sep. 30, 2015
Convertible Notes Payable [Abstract]
LOAN PAYABLE	NOTE 6 – LOAN PAYABLE On July 7, 2015, the Company entered into a loan agreement, providing for the issuance of a loan in the principal amount of $25,000. The term of the loan is for a period of 60 days from the execution of the agreement with a twenty-day grace period. The annual interest rate for the loan is 10%. The Company paid the lender additional consideration of 75,000 shares of common stock valued at $3,600 and recorded as interest expense. At September 30, 2015, the outstanding principal balance of the loan was $25,000 and $589 of accrued interest.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS Effective November 1, 2014, the Company entered into a service agreement with CFO Oncall Inc., a company majority owned by the Company’s Chief Financial Officer. In accordance with the service agreement, the service fee is $5,000 per month, which is payable as $3,000 in cash payable in advance on the 1 st

Convertible Notes Payable

Convertible Notes Payable	6 Months Ended
	Sep. 30, 2015
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 8 – CONVERTIBLE NOTES PAYABLE Fiscal 2015 Convertible Notes In October and November 2014, the Company and 7 investors, subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Convertible Notes”) with an aggregate principal amount of $400,000. The Convertible Notes are due and payable on the third anniversary of the date of issuance through October 2017. The Investors are entitled, at their option, at any time after the issuance of these Convertible Notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.02. In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company’s stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes. The Penalty Conversion shall remain in effect until such time as the Company’s registration statement, including the Conversion Shares is declared effective by the SEC. In connection with the issuance of these Convertible Notes above, the Company determined that the terms of the Convertible Notes include a down-round provision under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments were accounted for as derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivative of $419,000 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes $383,125 with the remainder $35,875 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract was recorded as a component of other income/(expense) in the accompanying consolidated statements of operations. In July 2015, the principal amount of $88,510 of this Fiscal 2015 Convertible Notes was converted into 4,425,500 shares of the Company’s common stock at the conversion price of $0.02 per share. At September 30, 2015, the principal amount due under this Fiscal 2015 Convertible Notes was $311,490. During the six months ended September 30, 2015, the fair value of the derivative liabilities were estimated using the Binomial option-pricing model with the following assumptions: Dividend rate 0 Term (in years) 2.04 to 2.29 years Volatility 121.91% to 195.81 % Risk-free interest rate 0.92% to 1.08 % At September 30, 2015, June 30, 2015, March 31, 2015 and on the conversion dates of this Fiscal 2015 Convertible Notes, the Company valued the embedded conversion option derivative liabilities resulting in a gain from change in fair value of derivative liabilities of $53,476 and $279,471, respectively, for the three and six months ended September 30, 2015. For the three and six months ended September 30, 2015, the embedded conversion option derivative liabilities of $188,327 were reclassified to additional paid-in capital upon the related notes conversion. For the three and six months ended September 30, 2015, amortization of debt discounts related to these convertible notes amounted to $90,799 and $122,726, respectively, which has been included in interest expense on the accompanying consolidated statements of operations. At September 30, 2015 and March 31, 2015, fiscal 2015 convertible promissory notes consisted of the following: September 30, 2015 March 31, 2015 Principal amount $ 311,490 $ 400,000 Less: unamortized debt discount (207,187 ) (329,913 ) Convertible notes payable, net $ 104,303 $ 70,087 Fiscal 2016 Convertible Notes Fiscal 2016 Convertible Notes with principal amount of $115,000 On May 19, 2015 and June 1, 2015 and June 23, 2015, the Company and 5 investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Fiscal 2016 Convertible Notes”) with an aggregate principal amount of $115,000. These convertible notes are due and payable on the third anniversary of the date of May 19, 2018 and June 1, 2018 and June 23, 2018. The Investors are entitled, at their option, at any time after the issuance of these convertible notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.05. The conversion price of the convertible notes shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price. On August 31, 2015, the conversion price of $0.05 per share was amended to $0.035 per share since the Company issued additional convertible notes with conversion price of $0.035 (see Fiscal 2016 Convertible Notes with principal amount of $56,250). In connection with the issuance of these convertible notes, the Company issued five-year common stock purchase warrants (“Warrants”) exercisable at $0.07 per share. These investors received 20 Warrants for each dollar invested in the convertible notes. The exercise price of the Warrant shall be subject to adjustment for issuance of common stock at a consideration per share of less than the then-effective exercise price. On August 31, 2015, the exercise price of the Warrant of $0.07 per share was amended to $0.035 per share since the Company issued additional five-year common stock purchase warrants with exercise price of $0.035 (see Fiscal 2016 Convertible Notes with principal amount of $56,250). In connection with the issuance of these convertible notes, the Company determined that the terms of the convertible notes and the 2,300,000 warrants include down-round provisions under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments and the warrants were accounted for as a derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives and warrants derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivatives and warrants derivatives of $234,455 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes $115,000 with the remainder $119,455 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract will be recorded as a component of other income/(expense) in the consolidated statements of operations. Fiscal 2016 Convertible Notes with principal amount of $56,250 On August 31, 2015 and September 8, 2015 and September 25, 2015, the Company and 4 investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Fiscal 2016 Convertible Notes”) with an aggregate principal amount of $56,250. These convertible notes are due and payable on the third anniversary of the date of August 31, 2018 and September 8, 2018 and September 25, 2018. The Investors are entitled, at their option, at any time after the issuance of these convertible notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.035. The conversion price of the convertible notes shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price. In connection with the issuance of these convertible notes, the Company issued five-year common stock purchase warrants (“Warrants”) exercisable at $0.035 per share. These investors received 20 Warrants for each dollar invested in the convertible notes. The exercise price of the Warrants shall be subject to adjustment for issuance of common stock at a consideration per share of less than the then-effective exercise price. In connection with the issuance of these convertible notes, the Company determined that the terms of the convertible notes and the 1,125,000 warrants include down-round provisions under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments and the warrants were accounted for as a derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives and warrants derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivatives and warrants derivatives of $103,632 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes $56,250 with the remainder $47,382 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract will be recorded as a component of other income/(expense) in the consolidated statements of operations. During the six months ended September 30, 2015, the fair value of the derivative liabilities were estimated using the Binomial option-pricing model with the following assumptions: Dividend rate 0 Term (in years) 2.63 to 5.00 years Volatility 162.15% to 290.63 % Risk-free interest rate 0.92% to 1.71 % At September 30, 2015, June 30, 2015 and on the initial measurements of the derivative liabilities, the Company valued the embedded conversion option derivative liabilities and the warrants derivative liabilities resulting in a loss from change in fair value of derivative liabilities of $56,770 and $23,265, respectively, for the three and six months ended September 30, 2015. For the three and six months ended September 30, 2015, amortization of debt discounts related to these convertible notes amounted to $10,364 and $13,559, respectively, which has been included in interest expense on the accompanying consolidated statements of operations. At September 30, 2015 and March 31, 2015, fiscal 2016 convertible promissory notes consisted of the following: September 30, March 31, Principal amount $ 171,250 $ - Less: unamortized debt discount (157,691 ) - Convertible notes payable, net $ 13,559 $ - At September 30, 2015 and March 31, 2015, the total convertible promissory notes mentioned above consisted of the following: September 30, 2015 March 31, 2015 Principal amount $ 482,740 $ 400,000 Less: unamortized debt discount (364,878 ) (329,913 ) Convertible notes payable, net $ 117,862 $ 70,087

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended
	Sep. 30, 2015
Stockholders' Deficit [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 9 – STOCKHOLDERS’ DEFICIT Authorized shares The Company is authorized to issue 10,000,000 shares of its $0.001 par value preferred stock. As of September 30, 2015 and March 31, 2015, no shares were issued and outstanding. The Company is authorized to issue 190,000,000 shares of its $0.001 par value common stock. As of September 30, 2015 and March 31, 2015, 44,630,056 and 36,951,165 shares of common stock were issued and outstanding, respectively. Common stock issued for services On April 27, 2015, the Company issued 100,000 restricted shares of common stock to an attorney for services rendered. The shares were valued at the fair market value of $0.06 per share based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $6,000 for the six months ended September 30, 2015. On May 1, 2015, the Company issued 180,000 restricted shares of common stock to an attorney for services to be rendered. The shares were valued at the fair market value of $0.0549 per share based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $4,118 for the six months ended September 30, 2015 and had a remaining prepaid expense of $5,764 at September 30, 2015, which will be amortized over the remaining service period. On May 1, 2015, the Company issued 175,000 vested shares of common stock to an attorney for services to be rendered. The shares were valued at the fair market value of $0.0549 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based legal fees of $4,000 for the six months ended September 30, 2015 and had a remaining prepaid expense of $5,608 at September 30, 2015, which will be amortized over the remaining service period. On June 1, 2015, the Company issued 726,989 restricted shares of common stock to a company controlled by the Company’s Chief Financial Officer for compensation and to settle accrued liabilities of $26,667 pursuant to the related service agreement (See Note 7). The shares were valued at $26,667 based on 60% of the closing bid price of the Company’s common stock on the last trading day of the previous quarter as defined in the service agreement. No gain or loss was recognized on this settlement. On June 1, 2015, the Company issued 250,000 vested shares of common stock to a consultant for marketing services to be rendered. The shares were valued at the fair market value of $0.054 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based marketing service fees of $4,500 for the six months ended September 30, 2015 and had a remaining prepaid expense of $9,000 at September 30, 2015, which will be amortized over the remaining service period. On July 1, 2015, the Company issued 100,000 vested shares of common stock to a consultant for web design services to be rendered. The shares were valued at the fair market value of $0.06 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based consulting fees of $1,500 for the six months ended September 30, 2015 and had a remaining prepaid expense of $4,500 at September 30, 2015, which will be amortized over the remaining service period. On August 5, 2015, the Company issued 181,818 restricted shares of common stock to a company controlled by the Company’s Chief Financial Officer for compensation and to settle accrued liabilities of $10,000 pursuant to the related service agreement (See Note 7). The shares were valued at $10,000 based on 60% of the closing bid price of the Company’s common stock on the last trading day of the previous quarter as defined in the service agreement. No gain or loss was recognized on this settlement. On August 5, 2015, the Company issued 125,000 vested shares of common stock to two accounting consultants for services rendered and 800,000 vested shares of common stock to two IT professionals for services rendered. The shares were valued at the fair market value of $0.04 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded stock-based accounting fees of $5,000 and stock-based consulting fees of $32,000, respectively, for the six months ended September 30, 2015. Common stock issued for notes conversion and accrued interest On July 9, 2015, $27,510 principal amount of the Company’s Fiscal 2015 Convertible Notes and $10,792 accrued interest were converted at $0.02 per share into 1,915,084 shares of the Company’s common stock. On July 22, 2015, $36,000 principal amount of the Company’s Fiscal 2015 Convertible Notes was converted at $0.02 per share into 1,800,000 shares of the Company’s common stock. On July 27, 2015, $25,000 principal amount of the Company’s Fiscal 2015 Convertible Notes was converted at $0.02 per share into 1,250,000 shares of the Company’s common stock. Common stock issued for loan fees On July 7, 2015, the Company issued 75,000 vested shares of common stock as additional consideration for a bridge loan. The shares were valued at the fair market value of $0.048 per share on the grant date which is the measurement date based on the closing bid price on the grant date. The Company recorded interest expense of $3,600 for the six months ended September 30, 2015. Reclassification of derivative liabilities upon notes conversion During the three months ended September 30, 2015, the Company reclassified $188,327 derivative liabilities to additional paid-in capital upon the conversion of Fiscal 2015 Convertible Notes with principal amount of $88,510. Warrants The Company issued warrants with the sale of common stock during the six months ended September 30, 2015. These warrants have an exercise price of $0.035 per share and expire in 5 years from issuance dates. Warrant activities for the six months ended September 30, 2015 were as follows: Number of Warrants Weighted Average Exercise Price Balance at March 31, 2015 1,048,315 $ 0.400 Issued 3,425,000 0.035 Exercised/forfeited/expired - - Balance at September 30, 2015 4,473,315 $ 0.121 Warrant exercisable at September 30, 2015 4,473,315 $ 0.121 The intrinsic value of the warrants was $34,250 at September 30, 2015. The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at September 30, 2015: Warrants Outstanding Warrants Exercisable Range of Number Range of Weighted Number Weighted $ 0.400 356,250 2.0 $ 0.400 356,250 $ 0.400 0.400 25,000 2.1 0.400 25,000 0.400 0.400 25,500 2.2 0.400 25,500 0.400 0.400 161,543 2.3 0.400 161,543 0.400 0.400 103,438 2.4 0.400 103,438 0.400 0.400 46,877 2.5 0.400 46,877 0.400 0.400 15,001 2.6 0.400 15,001 0.400 0.400 106,912 3.6 0.400 106,912 0.400 0.400 205,919 3.7 0.400 205,919 0.400 0.400 1,875 3.8 0.400 1,875 0.400 0.035 2,000,000 4.6 0.035 2,000,000 0.035 0.035 300,000 4.7 0.035 300,000 0.035 0.035 1,085,000 4.9 0.035 1,085,000 0.035 0.035 40,000 5.0 0.035 40,000 0.035 $ 0.035 – 0.400 4,473,315 2.0 – 5.0 $ 0.121 4,473,315 $ 0.121

Concentrations and Commitments

Concentrations and Commitments	6 Months Ended
	Sep. 30, 2015
Concentrations and Commitments [Abstract]
CONCENTRATIONS AND COMMITMENTS	NOTE 10 CONCENTRATIONS AND COMMITMENTS Concentrations Customers No customer accounted for 10% or more of the Company’s revenue during the three and six months ended September 30, 2015 and 2014. Suppliers No supplier accounted for 10% or more of the Company’s inventory purchases during the three and six months ended September 30, 2015 and 2014. Commitments Service contracts In September 2014, the Company signed an eight-month agreement with Applied DNA to work together, in good faith, on a business partnership focused on using Applied DNA Sciences’ unique SigNature© DNA taggant platform, digitalDNA © software platform and other products as required for DNA marking, tracking and authentication of sports collectibles and sports memorabilia uniquely and authentically identified to an athlete (“Goods”) and offered either within a True2Bid online auction exchange environment or through other means of sale. The agreement requires a cash payment of $35,000, of which $10,000 has been paid and the balance of $25,000 was scheduled to be paid in two payments of $12,500 each on February 1, 2015 and June 1, 2015. However, there has been no development pursuant to the three phases as defined in the agreement; accordingly, the Company believes no obligation exists and does not intend to pay these installments until the milestones are reached. This agreement expired in May 2015. In October 2015, the Company received a $10,000 refund from Applied DNA. On October 29, 2014, the Company entered into a service agreement with CFO Oncall, effective on November 1, 2014. In accordance to the service agreement, the service fee is $5,000 per month which is payable as follows: $3,000 in cash payable in advance of the 1 st On May 1, 2015, the Company entered into a one-year legal service agreement with an attorney who has agreed to provide corporate and securities related legal services to the Company. The agreement expires on April 30, 2016. In accordance to this legal service agreement, the Company pays (a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 restricted shares of the Company’s common stock. The Company issued the 175,000 restricted shares of common stock in June 2015 (See Note 9 – Common stock issued for service). The accrued service fees related to the service agreement at September 30, 2015 was $2,500, which was included in accounts payable and accrued liabilities. On May 1, 2015, the Company entered into a one-year consulting agreement with an attorney who has agreed to provide consulting services to the Company. The agreement expires on April 30, 2016. In accordance to this consulting agreement, the Company pays this consultant (a) $6,000 in equal monthly installments; and (b) 180,000 shares of the Company’s common stock. The Company issued the 180,000 shares of common stock in June 2015 (See Note 9 – Common stock issued for services). The accrued service fees related to the service agreement at September 30, 2015 was $2,000, which was included in accounts payable and accrued liabilities. On June 1, 2015, the Company entered into a one-year consulting agreement with a consultant who has agreed to provide consulting services to the Company. The agreement expires on May 31, 2016. In accordance to this consulting agreement, the Company pays the consultant (a) Per Tier 1 athlete/celebrity: (i) 2,500 restricted shares of the Company’s common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company’s common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company’s common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10 th On September 1, 2015, the Company entered into a consulting agreement with a consultant who has agreed to provide consulting services to the Company. The agreement can be terminated at any time by either party. In accordance to this consulting agreement, the Company pays the consultant (a) 75,000 shares of the Company’s common stock upon both parties signing this agreement; (b) 25,000 shares of the Company’s common stock per month, commencing at September 1, 2015 and continuing each month thereafter until this agreement has been terminated; (c) $2,000 per month, due and payable on the first of every month, commencing September 1, 2015; (d) 1,500 restricted shares of the Company’s common stock for each athlete, celebrity, or company that agrees to participate with the Company during the course of this agreement; (e) 1% of the revenue generated from the sales of original merchandise from athletes or celebrities consultant has participate with the Company during the course of this agreement. The consultant will be paid any commissions on the 10 th

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS Convertible note with principal amount of $40,000 On October 9, 2015, the Company and an investor (the “Investor”) entered into a convertible promissory note agreement, providing the issuance of a 10% convertible promissory note (the “Convertible Note”) with a principal amount of $40,000. The Convertible Note is due and payable on the third anniversary of the date of October 8, 2018. The Investor is entitled, at its option, at any time after the issuance of the Convertible Note, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.035. The conversion price of the convertible note shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price. In connection with the issuance of the convertible note, the Company issued five-year common stock purchase warrants (“Warrants”) exercisable at $0.035 per share. The investor received 20 Warrants for each dollar invested in the convertible note. The exercise price of the Warrant shall be subject to adjustment for issuance of common stock at a consideration per share of less than the then-effective exercise price. In connection with the issuance of the convertible note, the Company determined that the terms of the convertible note and the 800,000 warrants include down-round provisions under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instrument and the warrants were accounted for as a derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivative and warrants derivative was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivative and warrants derivative of $75,486 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the note $40,000 with the remainder $35,486 charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract will be recorded as a component of other income/(expense) in the consolidated statements of operations. Common stock issued for service On October 26, 2015, the Company issued 250,000 restricted shares of common stock to a consultant for services rendered and to be rendered. The shares were valued at the fair market value of $0.0389 per share based on the closing bid price on the grant date. The Company reduced accounts payable of $3,890 and recorded a prepaid expense of $5,835, which will be amortized over the remaining service period. LegacyXChange, Inc. is referred to herein as “we”, “our” or “us”.

Basis of Presentation, Going 18

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2015
Organization and Nature of Operations [Abstract]
Basis of presentation	Basis of presentation Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented. The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”) for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. These unaudited consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the years ended March 31, 2015 and 2014 included in the Company’s Form 10-K.
Going concern	Going concern These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net loss of $383,681 and $210,225 for the six months ended September 30, 2015 and 2014, respectively, and net cash used in operations of $200,050 and $118,246 for the six months ended September 30, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,999,644, $1,220,601 and $1,102,739, respectively, at September 30, 2015, did not generate any revenue for the six months ended September 30, 2015 and had a gross loss for the six months ended September 30, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The unaudited consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized.
Use of estimates	Use of estimates The preparation of the unaudited consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the three and six months ended September 30, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees.
Fair value of financial instruments and fair value measurements	Fair value of financial instruments and fair value measurements The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: ● Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. ● Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. ● Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the unaudited consolidated balance sheets for cash, inventories, accounts payable and accrued liabilities, accrued officer salary and director fees, and loan payable, approximate their fair market value based on the short-term maturity of these instruments. Certain financial instruments, such as certain accrued liabilities, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price. The following table reflects changes for the six months ended September 30, 2015 for all financial assets and liabilities categorized as Level 3: Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Increase in fair value of fixed monetary obligation - 12,000 Initial fair value of derivative liabilities attributable to conversion feature and warrants 338,087 - Reclassification of derivative liabilities upon notes conversion (188,327 ) - Decrease in fair value of fixed monetary obligation - (18,667 ) Gain from change in the fair value of derivative liabilities (256,206 ) - Balance as of September 30, 2015 $ 981,639 $ - ASC 825-10 “ Financial Instruments ,
Cash and cash equivalents	Cash and cash equivalents Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at September 30, 2015 and March 31, 2015.
Inventories and cost of revenue	Inventories and cost of revenue Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. Inventories of finished goods totaled $570 and $0 at September 30, 2015 and March 31, 2015, respectively.
Revenue recognition	Revenue recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows: ● Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred. ● To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life, which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days.
Stock-based compensation	Stock-based compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
Income taxes	Income taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of September 30, 2015 and March 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying unaudited consolidated financial statements.
Shipping costs	Shipping costs Shipping costs are included in other selling, general and administrative expense and totaled $2 and $20 for the three months ended September 30, 2015 and 2014, respectively. Shipping costs totaled $2 and $115 for the six months ended September 30, 2015 and 2014, respectively.
Advertising	Advertising Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the three and six months ended September 30, 2015 and 2014.
Research and development	Research and development Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the three and six months ended September 30, 2015 and 2014.
Basic and diluted earnings per share	Basic and diluted earnings per share Pursuant to ASC 260-10-45, basic earnings per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the three and six months ended September 30, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at September 30, 2015 and 2014 included the following: September 30, 2015 September 30, 2014 Stock warrants 4,473,315 1,048,315 Total 4,473,315 1,048,315
Related parties	Related parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged.
Recent accounting pronouncements	Recent accounting pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.

Basis of Presentation, Going 19

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Sep. 30, 2015
Organization and Nature of Operations [Abstract]
Schedule of financial assets and liabilities categorized as Level 3	Derivative Fixed Monetary Obligation Balance as of March 31, 2015 $ 1,088,085 $ 6,667 Increase in fair value of fixed monetary obligation - 12,000 Initial fair value of derivative liabilities attributable to conversion feature and warrants 338,087 - Reclassification of derivative liabilities upon notes conversion (188,327 ) - Decrease in fair value of fixed monetary obligation - (18,667 ) Gain from change in the fair value of derivative liabilities (256,206 ) - Balance as of September 30, 2015 $ 981,639 $ -
Schedule of aggregate common stock equivalents	September 30, 2015 September 30, 2014 Stock warrants 4,473,315 1,048,315 Total 4,473,315 1,048,315

Prepaid Expenses (Tables)

Prepaid Expenses (Tables)	6 Months Ended
	Sep. 30, 2015
Prepaid Expenses [Abstract]
Schedule of prepaid expenses	September 30, 2015 March 31, 2015 Prepaid professional service fees $ 38,952 $ 28,801 Prepaid other expense 350 - $ 39,302 $ 28,801

Accounts Payable and Accrued 21

Accounts Payable and Accrued Liabilities (Tables)	6 Months Ended
	Sep. 30, 2015
Accounts Payable and Accrued Liabilities [Abstract]
Schedule of accounts payable and accrued liabilities	September 30, 2015 March 31, 2015 Accrued interest $ 30,640 $ 17,693 Accrued professional fees 65,688 67,364 Accrued payroll taxes 33,456 28,690 Other 2,500 - $ 132,284 $ 113,747

Accrued Officer Salary and Di22

Accrued Officer Salary and Director Fees (Tables)	6 Months Ended
	Sep. 30, 2015
Accrued Officer Salary and Director Fees [Abstract]
Schedule of accrued officer salary and director fees	September 30, 2015 March 31, 2015 Accrued director's salary $ 3,250 $ 4,750 Accrued officer’s salary 1,000 3,300 $ 4,250 $ 8,050

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2015
Short-term Debt [Line Items]
Schedule of convertible promissory notes	September 30, 2015 March 31, 2015 Principal amount $ 482,740 $ 400,000 Less: unamortized debt discount (364,878 ) (329,913 ) Convertible notes payable, net $ 117,862 $ 70,087
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Schedule of fair value of the derivative liabilities	Dividend rate 0 Term (in years) 2.04 to 2.29 years Volatility 121.91% to 195.81 % Risk-free interest rate 0.92% to 1.08 %
Schedule of convertible promissory notes	September 30, 2015 March 31, 2015 Principal amount $ 311,490 $ 400,000 Less: unamortized debt discount (207,187 ) (329,913 ) Convertible notes payable, net $ 104,303 $ 70,087
Fiscal 2016 Convertible Notes [Member]
Short-term Debt [Line Items]
Schedule of fair value of the derivative liabilities	Dividend rate 0 Term (in years) 2.63 to 5.00 years Volatility 162.15% to 290.63 % Risk-free interest rate 0.92% to 1.71 %
Schedule of convertible promissory notes	September 30, March 31, Principal amount $ 171,250 $ - Less: unamortized debt discount (157,691 ) - Convertible notes payable, net $ 13,559 $ -

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	6 Months Ended
	Sep. 30, 2015
Stockholders' Deficit [Abstract]
Summary of warrant activities	Number of Warrants Weighted Average Exercise Price Balance at March 31, 2015 1,048,315 $ 0.400 Issued 3,425,000 0.035 Exercised/forfeited/expired - - Balance at September 30, 2015 4,473,315 $ 0.121 Warrant exercisable at September 30, 2015 4,473,315 $ 0.121
Summary of warrants outstanding	Warrants Outstanding Warrants Exercisable Range of Number Range of Weighted Number Weighted $ 0.400 356,250 2.0 $ 0.400 356,250 $ 0.400 0.400 25,000 2.1 0.400 25,000 0.400 0.400 25,500 2.2 0.400 25,500 0.400 0.400 161,543 2.3 0.400 161,543 0.400 0.400 103,438 2.4 0.400 103,438 0.400 0.400 46,877 2.5 0.400 46,877 0.400 0.400 15,001 2.6 0.400 15,001 0.400 0.400 106,912 3.6 0.400 106,912 0.400 0.400 205,919 3.7 0.400 205,919 0.400 0.400 1,875 3.8 0.400 1,875 0.400 0.035 2,000,000 4.6 0.035 2,000,000 0.035 0.035 300,000 4.7 0.035 300,000 0.035 0.035 1,085,000 4.9 0.035 1,085,000 0.035 0.035 40,000 5.0 0.035 40,000 0.035 $ 0.035 – 0.400 4,473,315 2.0 – 5.0 $ 0.121 4,473,315 $ 0.121

Basis of Presentation, Going 25

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details)	6 Months Ended
	Sep. 30, 2015USD ($)
Derivative Liabilities [Member]
Summary of financial assets and liabilities
Balance as of March 31, 2015	$ 1,088,085
Increase in fair value of fixed monetary obligation
Initial fair value of derivative liabilities attributable to conversion feature and warrants	$ 338,087
Reclassification of derivative liabilities upon notes conversion	$ (188,327)
Decrease in fair value of fixed monetary obligation
Gain from change in the fair value of derivative liabilities	$ (256,206)
Balance as of September 30, 2015	981,639
Fixed Monetary Obligation [Member]
Summary of financial assets and liabilities
Balance as of March 31, 2015	6,667
Increase in fair value of fixed monetary obligation	$ 12,000
Initial fair value of derivative liabilities attributable to conversion feature and warrants
Reclassification of derivative liabilities upon notes conversion
Decrease in fair value of fixed monetary obligation	$ (18,667)
Gain from change in the fair value of derivative liabilities
Balance as of September 30, 2015

Basis of Presentation, Going 26

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details 1) - shares	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	4,473,315	1,048,315
Stock warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	4,473,315	1,048,315

Basis of Presentation, Going 27

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2015
Basis of Presentation Going Concern and Summary of Significant Accounting Policies (Textual)
Net loss	$ (317,374)	$ (81,730)	$ (383,681)	$ (210,225)
Net cash used in operating activities			(200,050)	(118,246)
Accumulated deficit	(9,999,644)		(9,999,644)		$ (9,615,963)
Stockholders deficit	(1,220,601)		(1,220,601)		$ (1,246,806)
Working capital deficit	1,102,739		1,102,739
Inventories	570		570
Shipping costs	$ 2	$ 20	$ 2	$ 115

Prepaid Expenses (Details)

Prepaid Expenses (Details) - USD ($)	Sep. 30, 2015	Mar. 31, 2015
Prepaid Expenses [Abstract]
Prepaid professional service fees	$ 38,952	$ 28,801
Prepaid other expense	350
Total prepaid expenses	$ 39,302	$ 28,801

Accounts Payable and Accrued 29

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Sep. 30, 2015	Mar. 31, 2015
Accounts Payable and Accrued Liabilities [Abstract]
Accrued interest	$ 30,640	$ 17,693
Accrued professional fees	65,688	67,364
Accrued payroll taxes	33,456	$ 28,690
Other	2,500
Accounts payable and accrued liabilities, Total	$ 132,284	$ 113,747

Accrued Officer Salary and Di30

Accrued Officer Salary and Director Fees (Details) - USD ($)	Sep. 30, 2015	Mar. 31, 2015
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$ 4,250	$ 8,050
Director [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	3,250	4,750
Officer [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$ 1,000	$ 3,300

Accrued Officer Salary and Di31

Accrued Officer Salary and Director Fees (Detail Textual) - USD ($)	6 Months Ended
	Sep. 30, 2015	Mar. 31, 2015
Accrued Officer Salary and Director Fees (Textual)
Initial Payment	$ 1,500
Quarterly Payments	1,500
Accrued Salaries	4,250	$ 8,050
Director [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	3,250	4,750
Officer [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	$ 1,000	$ 3,300

Loan Payable (Details)

Loan Payable (Details) - USD ($)	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2015
Convertible Notes Payable [Abstract]
Issuance of loan in principal amount	$ 25,000
Loan annual interest rate	10.00%
Stock issued for loan additional consideration.	75,000
Stock issued for loan fees, value	$ 3,600
Loan outstanding principal balance	25,000
Accrued interest	$ 589

Related Party Transactions (Det

Related Party Transactions (Details) - Chief Financial Officer [Member] - USD ($)	Nov. 01, 2014	Oct. 29, 2014	Sep. 30, 2015
Related Party Transactions (Textual)
Cash paid in advance	$ 3,000
Amount paid in cash or common stock	$ 2,000
Servicing Fees		$ 5,000
Stock issued for accounts payable - related party, shares			726,989
Accrued liabilities			$ 15,000
Common stock restricted			181,818
Common stock closing bid price			$ 10,000
Common stock closing bid price percentage			60.00%

Convertible Notes Payable (Deta

Convertible Notes Payable (Details)	6 Months Ended
	Sep. 30, 2015
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Dividend rate	0.00%
Fiscal 2015 Convertible Notes [Member] | Maximum [Member]
Short-term Debt [Line Items]
Term (in years)	2 years 3 months 15 days
Volatility	195.81%
Risk-free interest rate	1.08%
Fiscal 2015 Convertible Notes [Member] | Minimum [Member]
Short-term Debt [Line Items]
Term (in years)	2 years 15 days
Volatility	121.91%
Risk-free interest rate	0.92%
Fiscal 2016 Convertible Notes [Member]
Short-term Debt [Line Items]
Dividend rate	0.00%
Fiscal 2016 Convertible Notes [Member] | Maximum [Member]
Short-term Debt [Line Items]
Term (in years)	5 years
Volatility	290.63%
Risk-free interest rate	1.71%
Fiscal 2016 Convertible Notes [Member] | Minimum [Member]
Short-term Debt [Line Items]
Term (in years)	2 years 7 months 17 days
Volatility	162.15%
Risk-free interest rate	0.92%

Convertible Notes Payable (De35

Convertible Notes Payable (Details 1) - USD ($)	Sep. 30, 2015	Mar. 31, 2015
Short-term Debt [Line Items]
Principal amount	$ 482,740	$ 400,000
Less: unamortized debt discount	(364,878)	(329,913)
Convertible notes payable, net	117,862	70,087
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Principal amount	311,490	400,000
Less: unamortized debt discount	(207,187)	(329,913)
Convertible notes payable, net	104,303	$ 70,087
Fiscal 2016 Convertible Notes [Member]
Short-term Debt [Line Items]
Principal amount	171,250
Less: unamortized debt discount	(157,691)
Convertible notes payable, net	$ 13,559

Convertible Notes Payable (De36

Convertible Notes Payable (Detail Textual)	1 Months Ended		3 Months Ended		6 Months Ended
	Aug. 31, 2015$ / shares	Jul. 31, 2015USD ($)$ / sharesshares	Sep. 30, 2015USD ($)Investors$ / shares	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)Investors$ / sharesshares	Sep. 30, 2014USD ($)	Mar. 31, 2015USD ($)
Short-term Debt [Line Items]
Principal amount of debt			$ 482,740		$ 482,740		$ 400,000
Convertible note interest rate			10.00%		10.00%
Debt Instrument, discount			$ 364,878		$ 364,878		$ 329,913
Initial derivative expense			47,382		166,837
Amortization of debt discount					$ 136,285
warrant issued | shares					3,425,000
Derivative liabilities reclassified to additional paid-in capital					$ 188,327
Fiscal 2015 Convertible Notes [Member]
Short-term Debt [Line Items]
Principal amount of debt			$ 400,000		$ 400,000
Convertible notes date of issuance					Oct. 31, 2017
Conversion share price | $ / shares		$ 0.02	$ 0.02		$ 0.02
Convertible note, description					In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company's stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes.
Initial fair value of derivative liabilities attributable to conversion feature					$ 419,000
Debt Instrument, discount			$ 383,125		383,125
Initial derivative expense					$ 35,875
Number of Investors | Investors			7		7
Amortization of debt discount			$ 90,799		$ 122,726
Principal amount used		$ 88,510
Convertible notes converted to shares | shares		4,425,500
Principal amount unused			311,490		311,490
Change in fair value of derivative liabilities			53,476		279,471
Derivative liabilities reclassified to additional paid-in capital			188,327		188,327
Fiscal 2016 Convertible Notes with principal amount of $115,000 [Member]
Short-term Debt [Line Items]
Principal amount of debt			$ 115,000		$ 115,000
Conversion share price | $ / shares	$ 0.035		$ 0.05		$ 0.05
Number of Investors | Investors			5		5
Initial derivative expense					$ 119,455
Derivative Liability			$ 234,455		$ 234,455
Warrants exercise price | $ / shares	0.035				$ 0.07
Number of conversion warrant | shares					2,300,000
Proceeds of issuance debt					$ 115,000
warrant issued | shares					2,300,000
Fiscal 2016 Convertible Notes with principal amount of $56,250 [Member]
Short-term Debt [Line Items]
Principal amount of debt			$ 56,250		$ 56,250
Conversion share price | $ / shares	$ 0.035
Number of Investors | Investors			4		4
Initial derivative expense					$ 47,382
Derivative Liability			$ 103,632		$ 103,632
Warrants exercise price | $ / shares					$ 0.035
Number of conversion warrant | shares					1,125,000
Proceeds of issuance debt					$ 56,250
Amortization of debt discount			10,364		13,559
Change in fair value of derivative liabilities			$ 56,770		$ 23,265

Stockholders' Deficit (Details)

Stockholders' Deficit (Details)	6 Months Ended
	Sep. 30, 2015$ / sharesshares
Stockholders' Deficit [Abstract]
Beginning balance | shares	1,048,315
warrant issued | shares	3,425,000
Exercised/forfeited/expired | shares
Ending balance | shares	4,473,315
Warrant exercisable at September 30, 2015 | shares	4,473,315
Weighted average exercise price, Beginning balance	$ 0.400
Weighted average exercise price, Issued	$ 0.035
Weighted average exercise price, Exercised/ forfeited/ expired
Weighted average exercise price, Ending balance	$ 0.121
Weighted average exercise price, Exercisable	$ 0.121

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - Warrant [Member]	6 Months Ended
	Sep. 30, 2015$ / sharesshares
Warrants Outstanding And Exercisable [Abstract]
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	4,473,315
Warrants Outstanding, Weighted Average Exercise Price	$ 0.121
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	4,473,315
Warrants Exercisable, Weighted Average Exercise Price	$ 0.121
Maximum [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	5 years
Minimum [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.035
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years
0.400 [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	356,250
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	356,250
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 One [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	25,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 1 month 6 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	25,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Two [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	25,500
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 2 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	25,500
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Three [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	161,543
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 3 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	161,543
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Four [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	103,438
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 4 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	103,438
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Five [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	46,877
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 6 months
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	46,877
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Six [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	15,001
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 7 months 6 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	15,001
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Seven [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	106,912
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 7 months 6 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	106,912
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Eight [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	205,919
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 8 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	205,919
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.400 Nine [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.400
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	1,875
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 9 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.400
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	1,875
Warrants Exercisable, Weighted Average Exercise Price	$ 0.400
0.035 Ten [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.035
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	2,000,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 7 months 6 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.035
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	2,000,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.035
0.035 Eleven [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.035
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	300,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 8 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.035
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	300,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.035
0.035 Twelve [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.035
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	1,085,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 10 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.035
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	1,085,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.035
0.035 Therteen [Member]
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$ 0.035
Warrants Outstanding, Number Outstanding at September 30, 2015 | shares	40,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	5 years
Warrants Outstanding, Weighted Average Exercise Price	$ 0.035
Warrants Exercisable, Number Exercisable at September 30, 2015 | shares	40,000
Warrants Exercisable, Weighted Average Exercise Price	$ 0.035

Stockholders' Deficit (Detail39

Stockholders' Deficit (Details Textual)	Oct. 26, 2015$ / shares	Jul. 27, 2015USD ($)$ / sharesshares	Jul. 22, 2015USD ($)$ / sharesshares	Jul. 09, 2015USD ($)$ / sharesshares	Jul. 06, 2015shares	Jul. 01, 2015$ / sharesshares	Jun. 01, 2015USD ($)$ / sharesshares	May. 01, 2015$ / sharesshares	Aug. 05, 2015USD ($)$ / sharesshares	Apr. 27, 2015$ / sharesshares	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)	Jul. 07, 2015$ / shares	Mar. 31, 2015$ / sharesshares
Stockholders' Deficit (Textual)
Preferred stock, shares authorized | shares											10,000,000		10,000,000			10,000,000
Preferred stock, par value | $ / shares											$ 0.001		$ 0.001			$ 0.001
Preferred stock, shares issued | shares
Preferred stock, shares outstanding | shares
Common stock, par value | $ / shares											$ 0.001		$ 0.001			$ 0.001
Common stock, shares authorized | shares											190,000,000		190,000,000			190,000,000
Stock issued for accounts payable - related party, value									$ 10,000				$ 36,667
Common stock, shares issued | shares											44,630,056		44,630,056			36,951,165
Common stock, shares outstanding | shares											44,630,056		44,630,056			36,951,165
Closing bid price									60
Stock issued for services, value									$ 10,000				$ 81,990
Accrued interest											$ 589		$ 589
Loss on settlement of loans														$ 5,510
Interest expense											117,120		$ 163,624
Derivative liabilities to additional paid-in capital											188,327		188,327
Stock issued for convertible notes principal													88,510
Common Stock [Member]
Stockholders' Deficit (Textual)
Stock issued for accounts payable - related party, value													$ 909
Common stock issued for services | shares													1,730,000
Stock issued for accounts payable - related party, shares | shares													908,807
Fair value of shares issued | $ / shares	$ 0.0389
Stock issued for services, value													$ 1,730
Convertible notes payable		$ 25,000	$ 36,000	$ 27,510
Accrued interest				$ 10,792
Conversion share price | $ / shares		$ 0.02	$ 0.02	$ 0.02
Conversion of Stock, Shares Issued | shares		1,250,000	1,800,000	1,915,084									4,425,500
Common Stock [Member] | Bridge Loan [Member]
Stockholders' Deficit (Textual)
Stock issued for payment for loan fees, shares | shares					75,000
Shares issued, price per share | $ / shares															$ 0.048
Interest expense													$ 3,600
Common Stock [Member] | Attorney [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares										100,000
legal fees													6,000
Fair value of shares issued | $ / shares										$ 0.06
Common Stock [Member] | Attorney One [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares								180,000
legal fees													4,118
Fair value of shares issued | $ / shares								$ 0.0549
Prepaid expense remaining amount											5,764		5,764
Common Stock [Member] | Law Firm [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares								175,000
legal fees													4,000
Fair value of shares issued | $ / shares								$ 0.0549
Prepaid expense remaining amount											5,608		5,608
Common Stock [Member] | Accounting Firm [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares							250,000
Fair value of shares issued | $ / shares							$ 0.054
Prepaid expense remaining amount							$ 9,000				9,000		9,000
Issuance of common stock, Value													4,500
Common Stock [Member] | Consultant [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares							250,000
Fair value of shares issued | $ / shares							$ 0.054
Prepaid expense remaining amount											9,000		9,000
Stock based consulting fees													4,500
Common Stock [Member] | Consultant One [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares						100,000			181,818
Fair value of shares issued | $ / shares						$ 0.06
Prepaid expense remaining amount											4,500		4,500
Stock based consulting fees													1,500
Common Stock [Member] | Consultant Two [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares									125,000
Fair value of shares issued | $ / shares									$ 0.04
Stock based consulting fees													32,000
Stock based accounting fees													$ 5,000
Common Stock [Member] | IT Professional [Member]
Stockholders' Deficit (Textual)
Common stock issued for services | shares									800,000
Fair value of shares issued | $ / shares									$ 0.04
Warrant [Member]
Stockholders' Deficit (Textual)
Term of warrants													5 years
Warrants exercise price | $ / shares													$ 0.035
Intrinsic value of the warrants											$ 34,250		$ 34,250
Restricted Stock [Member] | Service Agreement [Member]
Stockholders' Deficit (Textual)
Stock issued for accounts payable - related party, value							$ 26,667
Stock issued for accounts payable - related party, shares | shares							726,989
Closing bid price							60

Concentrations and Commitments

Concentrations and Commitments (Details) - USD ($)	Oct. 09, 2015	Sep. 01, 2015	Jun. 01, 2015	May. 01, 2015	Oct. 30, 2015	Oct. 29, 2014	Sep. 30, 2015	Mar. 31, 2015	Feb. 01, 2015	Sep. 30, 2014
Concentrations and Commitments (Textual)
Common stock, shares issued							44,630,056	36,951,165
Commitments, Description				(a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 shares of the Company's common stock. The Company issued the 175,000 shares of common stock in June 2015
Installments of cash paid				$ 1,000						$ 10,000
Agreement expired				The agreement expires on April 30, 2016.
Accounts payable and accrued liabilities.							$ 2,500
Increase in premium					$ 12,000
Decrease in premium					18,667
June 1, 2015
Concentrations and Commitments (Textual)
Common stock, shares issued			250,000
Commitments, Description		(a) 75,000 shares of the Company's common stock upon both parties signing this agreement; (b) 25,000 shares of the Company's common stock per month, commencing at September 1, 2015 and continuing each month thereafter until this agreement has been terminated; (c) $2,000 per month, due and payable on the first of every month, commencing September 1, 2015; (d) 1,500 restricted shares of the Company's common stock for each athlete, celebrity, or company that agrees to participate with the Company during the course of this agreement; (e) 1% of the revenue generated from the sales of original merchandise from athletes or celebrities consultant has participate with the Company during the course of this agreement. The consultant will be paid any commissions on the 10th of each month for revenue generated in the preceding month.	(a) Per Tier 1 athlete/celebrity: (i) 2,500 shares of the Company's common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company's common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company's common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10th of each month for revenue generated in the preceding month, and the first of every month for the $3,500 monthly payment.
Installments of cash paid			$ 3,500
Agreement expired			The agreement expires on May 31, 2016.
May 1, 2015
Concentrations and Commitments (Textual)
Common stock, shares issued				180,000
Commitments, Description				(a) $6,000 to be paid in equal monthly installments; and (b) 180,000 shares of the Company's common stock.
Installments of cash paid				$ 6,000
Agreement expired				The agreement expires on April 30, 2016.
Accounts payable and accrued liabilities.				$ 2,000
September 2,014
Concentrations and Commitments (Textual)
Cash payment										35,000
Installments of cash paid			$ 12,500						$ 12,500	$ 25,000
September 1, 2015
Concentrations and Commitments (Textual)
Common stock, shares issued		75,000
Installments of cash paid		$ 2,000
Accounts payable and accrued liabilities.		$ 5,890
Subsequent Event [Member]
Concentrations and Commitments (Textual)
Percentage of quoted market prices	10.00%
CFO Oncall Inc [Member]
Concentrations and Commitments (Textual)
Cash payment						$ 3,000
Service fees						$ 5,000
Percentage of quoted market prices						40.00%
Installments of cash paid						$ 2,000
Stock settled debt						2,000
Premium payment amount						1,333
Accumulated premium included in accounts payable							$ 0	$ 6,667
Accounts payable and accrued liabilities.						$ 2,000
Applied DNA Sciences [Member]
Concentrations and Commitments (Textual)
Customer refund payment amounts					$ 10,000

Subsequent Events (Details Text

Subsequent Events (Details Textual) - Subsequent Event [Member] - USD ($)	Oct. 26, 2015	Oct. 09, 2015
Subsequent Events (Textual)
Principal amount of convertible promissory note		$ 40,000
Debt instrument due date		Oct. 8, 2018
Percentage of convertible promissory note		10.00%
Conversion share price		$ 0.035
Purchase warrants exercisable per share		$ 0.035
Purchase of warrants term		5 years
Warrant [Member]
Subsequent Events (Textual)
Stock issued for notes conversion, shares		800,000
Derivative liability		$ 75,486
Debt Instrument, discount		40,000
Derivative expense		$ 35,486
Common Stock [Member]
Subsequent Events (Textual)
Stock issued for services, shares	250,000
Accounts Payable	$ 3,890
Prepaid expense remaining amount	$ 5,835
Fair market value of per share	$ 0.0389